Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug duo aims to keep ovarian cancer at bay longer

NCT ID NCT06819007

Disease control Sponsor: Daiichi Sankyo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether adding trastuzumab deruxtecan (T-DXd) to standard bevacizumab maintenance therapy can delay cancer progression better than bevacizumab alone in people with HER2-expressing advanced ovarian cancer. About 582 adults whose cancer has a specific protein (HER2) will receive either the combination or single drug after initial chemotherapy. The study is currently recruiting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 582 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Jan 2032

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion Criteria: 1. Sign and date the tissue prescreening ICF, prior to HER2 central testing. Sign and date the Main ICF, prior to the start of any trial- specific qualification procedures. Consent to optional PGx prior to any PGx procedures. \*For participants in the safety run-in phase, a safety run-in ICF needs to be signed and dated prior to the start of any trial-specific qualification procedures. 2. Adults ≥18 years of age on the day of signing the ICF. Follow local regulatory requirements if the legal age of consent for trial participation is \>18 years old. 3. Has histologically confirmed diagnosis of epithelial high-grade ovarian, fallopian tube or primary peritoneal carcinoma per local assessment (including but not limiting to serous, endometrioid, clear cell, carcinosarcoma, mucinous). 4. Is newly diagnosed FIGO Stage III or IV. 5. Has HER2 expression per 2016 ASCO-CAP gastric cancer IHC scoring (3+/2+/1+) guidelines1 by prospective central testing. \*For participants in the safety run-in phase, HER2 expression assessed by either local (require using ASCO-CAP gastric cancer IHC scoring \[IHC 3+/2+/1+\] guidelines) or central assessment (if available) is acceptable. Submission of the pathology report is required for participants enrolled based on local HER2 IHC results. 6. Has adequate tumor tissue sample available for assessment of HER2 by central laboratory. Tumor tissue block or sufficient tissue slides are required for HER2 testing and retrospective HRD status determination. \*Participants in the safety run-in phase who are enrolled based on local HER2 IHC results are recommended to provide tumor tissue sample from the same specimen for central assessment. 7. Has a local HRD or BRCA test result available. Participants with BRCA-wildtype will have a local HRD test results, as applicable. 8. Has received up to 6 cycles of standard of care bevacizumab in combination with frontline platinum- based chemotherapy as per approved indication and clinical guidelines and is eligible to continue single agent bevacizumab maintenance per standard of care and investigator discretion. Key Exclusion Criteria: 1. Has ovarian, fallopian tube, or peritoneal cancer of non-epithelial origin. 2. Has a known or suspected deleterious BRCA alteration as per local test that makes the patient eligible for PARP inhibitor. 3. Participant to receive PARP inhibitor as maintenance per standard of care and investigator discretion. Reasons for which the participant is not eligible for PARP inhibitor will be recorded in the eCRF as follows: * HRD negative * HRD positive with SD as best response after platinum * HRD positive non-serous histology Note: For participants enrolled from the Republic of Korea * HRD tested, but inconclusive * HRD positive but safety concern (safety concern to be specified). 4. Has a history of severe hypersensitivity reactions to either the drug substances or inactive ingredients in the drug products and other monoclonal antibodies. 5. Previous Cerebral-Vascular Accident, Transient Ischemic Attack or Sub- Arachnoids Hemorrhage within 6 months prior to randomization. \*Note: For participants enrolled from the Republic of Korea, 6. Has evidence of bleeding diathesis or significant coagulopathy (in the absence of anticoagulation therapy). 7. Has a history of hemorrhagic disorders, abdominal fistula, gastrointestinal perforation, or active gastrointestinal bleeding within 6 months before randomization. 8. Evidence of active or ongoing bowel obstruction. 9. Has a medical history of myocardial infarction within 6 months before randomization, symptomatic congestive heart failure (New York Heart Association Class II to IV). Participants with troponin levels above the upper limit of normal at Screening (as defined by the manufacturer), and without any myocardial infarction related symptoms should have a cardiologic consultation during the Screening Period to rule out myocardial infarction. 10. Has a corrected QT interval prolongation to \>480 msec based on average of the Screening triplicate 12-lead ECG. 11. Has a history of (non-infectious) ILD/pneumonitis that required steroids, has current ILD/pneumonitis, or where suspected ILD/pneumonitis cannot be ruled out by imaging at Screening.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Advanced high-grade epithelial ovarian cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Carcinoma, Ovarian Epithelial ovarian cancer ovarian carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ovarian cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    208 sites in 25 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • AZ Sint-Lucas

    RECRUITING

    Ghent, Belgium

  • Aarhus University Hospital

    RECRUITING

    Aarhus, Denmark

  • Addenbrooke's Hospital

    RECRUITING

    Cambridge, United Kingdom

  • AdventHealth Cancer Institute

    RECRUITING

    Orlando, Florida, 32804, United States

  • Affiliated Hospital (Suzhou First People's Hospital)

    RECRUITING

    Suzhou, China

  • Aichi Cancer Center Hospital

    RECRUITING

    Nagoya, Japan

  • Akademiska Sjukhuset (Uppsala University Hospital)

    RECRUITING

    Uppsala, 75185, Sweden

  • Ann B Barshinger Cancer Institute

    RECRUITING

    Lancaster, Pennsylvania, 17601, United States

  • Aretaieio Hospital

    RECRUITING

    Athens, 11528, Greece

  • Asan Medical Center

    RECRUITING

    Seoul, South Korea

  • Avera Medical Group Gynecologic

    RECRUITING

    Sioux Falls, South Dakota, 57105, United States

  • Azienda Ospedaliera Per Lemergenza Cannizzaro

    RECRUITING

    Catania, Italy

  • Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS

    RECRUITING

    Bologna, Italy

  • Azienda Ospedaliera Universitaria Policlinico Umberto

    RECRUITING

    Roma, 00161, Italy

  • Azienda Ospedaliero Universitaria Citta Della Salute E Della Scienza Di Torino

    RECRUITING

    Torino, 10126, Italy

  • Azienda Ospedaliero Universitaria Pisana

    RECRUITING

    Pisa, Italy

  • Azienda Socio Sanitaria Territoriale Di Monza (Presidio San Gerardo)

    RECRUITING

    Monza, Italy

  • BP A Beneficencia Portuguesa de Sao Paulo

    RECRUITING

    São Paulo, Brazil

  • Barts Health NHS Trust

    RECRUITING

    London, United Kingdom

  • Beijing Cancer Hospital

    RECRUITING

    Beijing, China

  • Broward Health Medical Center

    RECRUITING

    Fort Lauderdale, Florida, 33316, United States

  • CHA Bundang Medical Center, CHA University

    RECRUITING

    Seongnam-si, South Korea

  • CHU Montpellier, Saint Eloi

    RECRUITING

    Montpellier, France

  • CHU Saint Etienne

    RECRUITING

    Saint-Etienne, France

  • CHU UCL Namur

    RECRUITING

    Namur, Belgium

  • CRLCC Eugene Marquis

    RECRUITING

    Rennes, France

  • Cancer Institute Hospital of JFCR

    RECRUITING

    Kōtoku, 135-8550, Japan

  • Centre Georges Francois Leclerc

    RECRUITING

    Dijon, France

  • Centre Leon Berard

    RECRUITING

    Lyon, France

  • Centro De Pesquisas Clinica Reichow

    RECRUITING

    Blumenau, Brazil

  • Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa Hospital Mae de Deus

    RECRUITING

    Porto Alegre, Brazil

  • Ceon Pesquisas

    RECRUITING

    Santo André, Brazil

  • Chang Gung Memorial Hospital

    RECRUITING

    Linkou Taoyuan, Taiwan

  • Chongqing Cancer Hospital

    RECRUITING

    Chongqing, China

  • Clinica Universidad de Navarra (Calle Marquesado de Santa Marta)

    RECRUITING

    San Blas-Canillejas, Spain

  • Clinica Universidad de Navarra (MAD)

    RECRUITING

    Pamplona, Spain

  • Cliniques Universitaires Saint-LUC

    RECRUITING

    Woluwe-Saint-Lambert, Belgium

  • Columbia University

    RECRUITING

    New York, New York, 10032, United States

  • Complejo Hospitalario Universitario A Coruna

    RECRUITING

    A Coruña, Spain

  • Complex Oncology Center- Plovdiv EOOD

    RECRUITING

    Plovdiv, Bulgaria

  • Corewell Health

    RECRUITING

    Grand Rapids, Michigan, 49503, United States

  • Dana-Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Debreceni Egyetem

    RECRUITING

    Debrecen, 4032, Hungary

  • Disney Family Cancer Center

    RECRUITING

    Burbank, California, 91505, United States

  • Endeavor Health Evanston Kellogg Cancer Care Center

    RECRUITING

    Evanston, Illinois, 60201, United States

  • Fakultni Nemocnice Bulovka

    RECRUITING

    Prague, Czechia

  • Fakultni Nemocnice Kralovske Vinohrady

    RECRUITING

    Prague, Czechia

  • Fakultni Nemocnice Ostrava

    RECRUITING

    Ostrava-Poruba, Czechia

  • Fakultni Nemocnice V Motole

    RECRUITING

    Prague, Czechia

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    RECRUITING

    Roma, Italy

  • Fudan University Shanghai Cancer Center

    RECRUITING

    Shanghai Shi, 200032, China

  • Fujian Cancer Hospital

    RECRUITING

    Fuzhou, China

  • Fukushima Medical University Hospital

    RECRUITING

    Fukushima, 960-1295, Japan

  • Fundacao Faculdade Regional De Medicina De Sao Jose Do Rio Preto

    RECRUITING

    Sao Jose Rio, Brazil

  • Fundação Doutor Amaral Carvalho

    RECRUITING

    Jaú, Brazil

  • Gangnam Severance Hospital, Yonsei University Health System

    RECRUITING

    Seoul, South Korea

  • General Hospital of Athens Alexandra

    RECRUITING

    Athens, 11528, Greece

  • Genesis Care North Shore (Oncology)

    RECRUITING

    St Leonards, Australia

  • Genesis Care, Beaumont House

    RECRUITING

    Oxford, OX4 6LB, United Kingdom

  • Genesiscare St Andrews Hospital

    RECRUITING

    Adelaide, Australia

  • Gral Medical S.R.L

    RECRUITING

    Bucharest, Romania

  • Greater Baltimore Medical Center

    RECRUITING

    Towson, Maryland, 21204, United States

  • Groupe Sante CHC/Clinique du MontLegia

    RECRUITING

    Liège, Belgium

  • Guangxi Medical University Cancer Hopstial

    RECRUITING

    Nanning, China

  • Gujarat Cancer & Research Institute

    RECRUITING

    Ahmedabad, India

  • Guys Hospital Cancer Centre

    RECRUITING

    London, SE1 9RT, United Kingdom

  • Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz

    RECRUITING

    Győr, 9024, Hungary

  • HCG Cancer Centre Vadodara

    RECRUITING

    Vadodara, India

  • HCG Manavata Cancer Centre

    RECRUITING

    Nashik, India

  • HOSPITAL KUALA LUMPUR(HKL) Kuala

    RECRUITING

    Lumpur, Malaysia

  • Hainan General Hospital

    RECRUITING

    Haikou, China

  • Harbin Medical University - Tumor Hospital

    RECRUITING

    Haerbing, China

  • Henan Cancer Hospital

    RECRUITING

    Zhengzhou, China

  • Hopital Claude Huriez- CHU Lille

    RECRUITING

    Lille, France

  • Hopital Prive Du Confluent

    RECRUITING

    Nantes, France

  • Hopital Saint Joseph- Paris

    RECRUITING

    Paris, France

  • Hospital Clinic De Barcelona

    RECRUITING

    Barcelona, Spain

  • Hospital Clinico Universitario De Valencia

    RECRUITING

    Valencia, Spain

  • Hospital Europeen Georges Pompidou

    RECRUITING

    Paris, France

  • Hospital Sultan

    RECRUITING

    Johor Bahru, Malaysia

  • Hospital Universitari I Politecnic La Fe

    RECRUITING

    Valencia, Spain

  • Hospital Universitari Son Espases

    RECRUITING

    Palma, Spain

  • Hospital Universitari Vall D'Hebron

    RECRUITING

    Barcelona, Spain

  • Hospital Universitario 12 de Octubre

    RECRUITING

    Madrid, Spain

  • Hospital Universitario Donostia

    RECRUITING

    Planta Baja, Spain

  • Hospital Universitario La Paz

    RECRUITING

    Madrid, Spain

  • Hospital Universitario Ramon y Cajal

    RECRUITING

    Madrid, Spain

  • Hospital Universitario Reina Sofia

    RECRUITING

    Córdoba, Spain

  • Hospital Universitario Virgen De La Arrixaca

    RECRUITING

    El Palmar, Spain

  • Hospital Universitario Virgen del Rocio

    RECRUITING

    Seville, Spain

  • Hubei Cancer Hospital

    RECRUITING

    Wuhan, China

  • Humanitas San Pio X

    RECRUITING

    Milan, Italy

  • Hunan Cancer Hospital

    RECRUITING

    Changsha, 410006, China

  • Hyogo Cancer Center

    RECRUITING

    Akashi, 673-8558, Japan

  • IEO Istituto Europeo Di Oncologia

    RECRUITING

    Milan, Italy

  • Icahn School of Medicine at Mount Sinai

    RECRUITING

    New York, New York, 10029, United States

  • Icon Cancer Centre Hobart

    RECRUITING

    Hobart, Australia

  • Icon Cancer Centre Wesley

    RECRUITING

    Auchenflower, Australia

  • Indiana University

    RECRUITING

    Indianapolis, Indiana, 46202, United States

  • Institut Bergonie

    RECRUITING

    Bordeaux, France

  • Irmandade Da Santa Casa De Misericordia De Porto Alegre

    RECRUITING

    Porto Alegre, Brazil

  • Istituto Nazionale Tumori Fondazione G. Pascale

    RECRUITING

    Naples, Italy

  • Istituto Nazionale Tumori Regina Elena Irccs

    RECRUITING

    Roma, Italy

  • Istituto Tumori Giovanni Paolo II Irccs Ospedale Oncologico Bari

    RECRUITING

    Bari, Italy

  • Iwate Medical University Hospital

    RECRUITING

    Shiwa-Gun, 028-3695, Japan

  • Jiangxi Maternal and Child Health Hospital

    RECRUITING

    Nanchang, China

  • Jupiter Medical Center

    RECRUITING

    Jupiter, Florida, 33458, United States

  • Kaohsiung Chang Gung Memorial Hospital

    RECRUITING

    Kaohsiung City, Taiwan

  • Karolinska Universitet Ssjukhuset

    RECRUITING

    Solna, Sweden

  • Keimyung University Dongsan Hospital

    RECRUITING

    Daegu, South Korea

  • Kindai University Hospital

    RECRUITING

    Osakasayama-shi, Japan

  • King George Hospital

    RECRUITING

    Visakhapatnam, India

  • Kurume University Hospital

    RECRUITING

    Kurume-shi, Japan

  • Laura and Isaac Perlmutter Cancer Center at NYU Langone

    RECRUITING

    New York, New York, 10016, United States

  • Legacy Medical Group Gynecologic Oncology

    RECRUITING

    Portland, Oregon, 97210, United States

  • Liaoning Cancer Hospital & Institute

    RECRUITING

    Shenyang, China

  • Liga Norte-Rio-Grandense Contra o Cancer

    RECRUITING

    Natal, Brazil

  • MHAT Park Hospital EOOD

    RECRUITING

    Plovdiv, Bulgaria

  • MHAT Serdika EOOD

    RECRUITING

    Sofia, Bulgaria

  • MacKay Memorial Hospital- Taipei Branch

    RECRUITING

    Taipei, Taiwan

  • Mahamana Pandit Madan Mohan Malaviya Cancer Centre

    RECRUITING

    Varanasi, 221005, India

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

  • Mazowiecki Szpital Wojewodzki W Siedlcach SP Zoo

    RECRUITING

    Siedlce, Poland

  • Medeuropa SRL

    RECRUITING

    Bucharest, Romania

  • Medeuropa SRL

    RECRUITING

    Oradea, Romania

  • Medizinische Universitat Innsbruck

    RECRUITING

    Innsbruck, Austria

  • Meir Medical Center

    RECRUITING

    Kfar Saba, Israel

  • Memorial Healthcare International SRL

    RECRUITING

    Bucharest, Romania

  • Metropolitan Hospital

    RECRUITING

    Neo Faliro, 18547, Greece

  • Miami Valley Hospital South

    RECRUITING

    Centerville, Ohio, 45459, United States

  • Mie University Hospital

    RECRUITING

    Tsu, 514-8507, Japan

  • Minnesota Oncology Hematology PA

    RECRUITING

    Minneapolis, Minnesota, 55404, United States

  • Mount Sinai Medical Center

    RECRUITING

    Miami Beach, Florida, 33140, United States

  • NHO Hokkaido Cancer Center

    RECRUITING

    Sapporo, 003-0804, Japan

  • Nancy N. & J.C Lewis Cancer & Research Pavillion- St. Josephs/ Candler Health System

    RECRUITING

    Savannah, Georgia, 31405, United States

  • National And Hapodistrian University of Athens (University General Hospital Attikon)

    RECRUITING

    Athens, 12462, Greece

  • National Cancer Center

    RECRUITING

    Goyang-si, South Korea

  • National Cancer Center Hospital

    RECRUITING

    Chūōku, 104-0045, Japan

  • National Cancer Centre Singapore

    RECRUITING

    Singapore, 168583, Singapore

  • National Cancer Institute / Institut Kanser Negara

    RECRUITING

    Putrajaya, Malaysia

  • National Cancer Institute Nagpur

    RECRUITING

    Nagpur, India

  • National Cheng Kung University Hospital

    RECRUITING

    Tainan, Taiwan

  • National Taiwan University Hospital

    RECRUITING

    Taipei, Taiwan

  • National University Hospital

    RECRUITING

    Singapore, Singapore

  • Niigata Cancer Center Hospital

    RECRUITING

    Niigata, Japan

  • Nuovo Ospedale Degli Infermi

    RECRUITING

    Ponderano, Italy

  • Okayama University Hosptial

    RECRUITING

    Okayama, 700-8558, Japan

  • Oncocentro Belo Horizonte

    RECRUITING

    Belo Horizonte, Brazil

  • Osaka International Cancer Institute

    RECRUITING

    Osaka, Japan

  • Palo Alto Medical Foundation

    RECRUITING

    Palo Alto, California, 94301, United States

  • Providence Cancer Center Oncology

    RECRUITING

    Portland, Oregon, 97213, United States

  • Rabin Medical Center-Beilinson Campus

    RECRUITING

    Petah Tikva, Israel

  • Rigshospitalet

    RECRUITING

    Copenhagen, 2100, Denmark

  • Ruby Hall Clinic

    RECRUITING

    Pune, India

  • Saitama Medical University International Medical Center

    RECRUITING

    Hidaka-Shi, 350-1298, Japan

  • Samsung Medical Center

    RECRUITING

    Seoul, South Korea

  • Sarah Cannon Research Institute (Oncology Associates of Oregon PC)

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Sarawak General Hospital

    RECRUITING

    Kuching, Malaysia

  • Saroj Gupta Cancer Center and Research Institute SGCC&RI

    RECRUITING

    Kolkata, India

  • Scripps Clinic

    RECRUITING

    La Jolla, California, 92037, United States

  • Seoul National University Bundang Hospital

    RECRUITING

    Seongnam-si, South Korea

  • Seoul National University Hospital

    RECRUITING

    Seoul, South Korea

  • Severance Hospital, Yonsei University Health System

    RECRUITING

    Seoul, South Korea

  • Shaare Zedek

    RECRUITING

    Jerusalem, Israel

  • Shandong Cancer Hospital

    RECRUITING

    Jinan, China

  • Shanxi Cancer Hospital

    RECRUITING

    Taiyuan, China

  • Sheba Medical Center

    RECRUITING

    Tel Litwinsky, Israel

  • Shizuoka Cancer Center

    RECRUITING

    Sunto-gun, Japan

  • Sichuan University West China Second University Hospital

    RECRUITING

    Chengdu, China

  • Sjællands Universitet Hospital

    RECRUITING

    Roskilde, Denmark

  • Skanes Universitetssjukhus Lund

    RECRUITING

    Lund, Sweden

  • St Luke's Hospital

    RECRUITING

    Thessaloniki, 55236, Greece

  • St. Lukes University Health Network

    RECRUITING

    Bethlehem, Pennsylvania, 18015, United States

  • St. Vincent Gynecologic Oncology

    RECRUITING

    Billings, Montana, 59102, United States

  • Sun Yat-Sen University Cancer Center

    RECRUITING

    Guangzhou, China

  • Taichung Veterans General Hospital

    RECRUITING

    Taichung, Taiwan

  • Taipei Veterans General Hospital

    RECRUITING

    Taipei, Taiwan

  • Tata Memorial Hospital

    RECRUITING

    Mumbai, 400012, India

  • Tel Aviv Sourasky Medical Center

    RECRUITING

    Tel Aviv, Israel

  • The Catholic University of Korea, Seoul St. Mary'S Hospital

    RECRUITING

    Seoul, South Korea

  • The Christie Hospital

    RECRUITING

    Manchester, United Kingdom

  • The First Affiliated Hospital of Xi'an Jiaotong University

    RECRUITING

    Xi'an, China

  • The First Hospital of Jilin University

    RECRUITING

    Changchun, China

  • The Lady Davis Carmel Medical Center

    RECRUITING

    Haifa, Israel

  • The Second Hospital of Dalian Medical University

    RECRUITING

    Dalian, China

  • Tianjin Medical University Cancer Institute & Hospital

    RECRUITING

    Tianjin, China

  • Tongji Hospital Tongji Medical College of HUST

    RECRUITING

    Wuhan, China

  • Townsville University Hospital Cancer Centre

    RECRUITING

    Townsville, 4814, Australia

  • Trials365 LLC

    RECRUITING

    Shreveport, Louisiana, 71103, United States

  • Trinity Health St. Joseph Mercy Ann Arbor

    RECRUITING

    Ann Arbor, Michigan, 48106, United States

  • UMHAT Sofiamed EOOD

    RECRUITING

    Sofia, Bulgaria

  • UMHAT Tsaritsa Yoanna ISUL EAD

    RECRUITING

    Sofia, Bulgaria

  • UNC Hospital

    RECRUITING

    Chapel Hill, North Carolina, 27599, United States

  • UZ Leuven

    RECRUITING

    Leuven, Belgium

  • Uniwersytecki Szpital Kliniczny w Poznaniu

    RECRUITING

    Poznan, 61848, Poland

  • Ushato Prof Ivan Chernozemski Ead

    RECRUITING

    Sofia, Bulgaria

  • Utah Cancer Specialists Network

    RECRUITING

    Salt Lake City, Utah, 84106, United States

  • Valley Health System

    RECRUITING

    Paramus, New Jersey, 07652, United States

  • Vseobecna Fakultni Nemocnice V Praze

    RECRUITING

    Prague, Czechia

  • Westmead Hospital

    RECRUITING

    Sydney, Australia

  • Weston Park Hospital

    RECRUITING

    Sheffield, S10 2SB, United Kingdom

  • Woman's Care FL

    RECRUITING

    St. Petersburg, Florida, 33713, United States

  • Women's Hospital School of Medicine Zhejiang University

    RECRUITING

    Hangzhoushi, China

  • Yamagata University Hospital

    RECRUITING

    Yamagata, 990-9585, Japan

  • Yantai Yuhuangding Hospital

    RECRUITING

    Yantai, China

  • Yunnan Cancer Hospital

    RECRUITING

    Kunming, China

  • Zhejiang Cancer Hospital

    RECRUITING

    Hangzhou, China

  • Zhong Da Hospital, Southeast University

    RECRUITING

    Nanjing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.